Cosmetics and Personal Care Manufacturing in the Dominican Republic

The Dominican Republic’s cosmetics and personal care manufacturing sector is an emerging growth category within the Caribbean Economic Corridor, serving US brands seeking nearshore co-manufacturing for skincare, haircare, body care, and color cosmetics under CAFTA-DR zero-tariff conditions. A combination of affordable skilled labor, FDA-registration-capable facilities, and proximity to the US Hispanic beauty market — one of the fastest-growing consumer segments in US cosmetics — creates a compelling manufacturing proposition for US personal care brands evaluating their supply chain options.

Dominican Republic cosmetics manufacturing benefits from an existing regulatory infrastructure built around the MISPAS framework for health product oversight and growing FDA registration experience among free zone personal care operators. While the sector is less mature than medical devices or apparel, investment momentum since 2022 has accelerated capability development in line with broader CEC manufacturing growth trends.

Personal Care Manufacturing Capabilities

FDA Cosmetic Compliance Requirements

Cosmetics imported into the United States from the Dominican Republic must comply with FDA cosmetic regulations under the Federal Food, Drug, and Cosmetic Act and the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). Key MoCRA requirements for DR cosmetics manufacturers include: facility registration with FDA (required by December 2023 for large facilities, phased for small businesses); product listing with FDA; serious adverse event reporting; cosmetic product safety substantiation; and facility inspection compliance. DR manufacturers with existing FDA registration infrastructure from pharmaceutical or medical device operations are well-positioned for MoCRA compliance; new entrants need to build MoCRA compliance programs before first US export.

CAFTA-DR Tariff Treatment for Cosmetics

Cosmetics and personal care products manufactured in the Dominican Republic and qualifying under CAFTA-DR rules of origin enter the United States at zero duty. Standard US MFN tariff rates on cosmetics range from 0-6.5% depending on product type (HTS Chapter 33). For skincare products at 6.5% MFN, CAFTA-DR eliminates the tariff entirely. On $5 million in annual US cosmetics imports, this represents $325,000 in annual duty savings versus non-treaty sourcing.

Investment Case

US cosmetics brands evaluating DR co-manufacturing benefit from: CAFTA-DR zero-duty access and 3-4 day replenishment cycles enabling just-in-time inventory management; lower co-manufacturing costs versus US domestic contract manufacturers (estimated 30-50% labor cost reduction); access to authentic Caribbean and tropical botanical ingredients with supply chain proximity; and free zone tax incentives for manufacturing operations structured under CNZFE registration. The CEC framework supports cosmetics manufacturing investors through site facilitation, regulatory navigation, and capital introduction services.

Related Resources

DR Business Registration | ISO Quality Management | DR Food Processing & Agribusiness | Caribbean Shipping Routes

Frequently Asked Questions

Does MoCRA apply to foreign cosmetics manufacturers exporting to the US?

Yes. MoCRA’s facility registration and product listing requirements apply to facilities that manufacture or process cosmetics for US distribution, regardless of whether they are located in the United States or abroad. Dominican Republic cosmetics manufacturers exporting to the US must register their facilities with FDA and list their products. The registration deadline for large facilities was December 2023; small businesses had until December 2024. Non-compliant foreign facilities risk import detention.

Can a US cosmetics brand launch a DR-manufactured product line targeting the Hispanic market?

Yes, and several US beauty brands have done so successfully. A DR co-manufacturing relationship provides authentic Caribbean origin credentials, proximity-enabled freshness for natural formulations, and CAFTA-DR cost advantages. Brand development resources including formulation houses, contract manufacturers, and packaging suppliers serving the Dominican market can be accessed through PROINVERSION and AmCham DR supplier networks.

Explore More: EGS Insights Hub | DR Manufacturing Sectors | Contact Our Team